Theranostic application of miR-429 in HER2+breast cancer

Cava, C; Novello, C; Martelli, C; Lodico, A; Ottobrini, L; Piccotti, F; Truffi, M; Corsi, F; Bertoli, G; Castiglioni, I

Bertoli, G (corresponding author), CNR, Natl Res Council, IBFM, Inst Mol Bioimaging & Physiol, Via F Cervi 93, I-20090 Milan, Italy.

THERANOSTICS, 2020; 10 (1): 50

Abstract

Human epidermal growth factor receptor 2 (HER2) is overexpressed/amplified in one third of breast cancers (BCs), and is associated with the poorer pro......

Full Text Link